An Act to promote transparency in prescription drug prices
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This bill aims to increase transparency around prescription drug prices in Massachusetts. It will conduct an affordability review of prescription drugs to understand why prices are high. The goal is to identify ways to make medications more affordable for patients. This legislation builds upon previous attempts to address this issue.
Key provisions
- Conduct an affordability review of prescription drug prices.
- Analyze the factors contributing to high drug costs.
- Identify potential solutions to improve affordability.
- The review will be overseen by the committee on Health Care Financing.
Who is affected
- Patients
- Prescription drug manufacturers
- Healthcare providers
- Massachusetts residents
Notable changes
- This bill seeks to establish a formal process for examining drug pricing.
- It is similar to previous bills aimed at increasing transparency and affordability.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours